Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus

Despite many clinical trials conducted with oncolytic viruses, the exact tumor-level mechanisms affecting therapeutic efficacy have not been established. Currently there are no biomarkers available that would predict the clinical outcome to any oncolytic virus. To assess the baseline immunological p...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Ther
Autori principali: Taipale, Kristian, Liikanen, Ilkka, Juhila, Juuso, Turkki, Riku, Tähtinen, Siri, Kankainen, Matti, Vassilev, Lotta, Ristimäki, Ari, Koski, Anniina, Kanerva, Anna, Diaconu, Iulia, Cerullo, Vincenzo, Vähä-Koskela, Markus, Oksanen, Minna, Linder, Nina, Joensuu, Timo, Lundin, Johan, Hemminki, Akseli
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2016
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4754537/
https://ncbi.nlm.nih.gov/pubmed/26310629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2015.143
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi